Sign in

CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company

Verastem, Inc.

Sign in to watch
Ticker
VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
273269467
Phone
(781) 292-4200
Business address
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
  1. 10-K Report Annual Report
  2. 4 Open-market sale President and CEO sold 244 shares at $6.95 ($1,696)
  3. 4 Open-market sale Director sold 284 shares at $6.95 ($1,974)
  4. 4 Open-market sale Director sold 593 shares at $6.95 ($4,121)
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 4 Open-market sale President and CEO sold 858 shares at $5.70 ($4,891)
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. 8-K Event Regulation FD disclosure · Other events
  15. 8-K Event Executive or director change
  16. 3 Insider Initial Statement of Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 4 Open-market sale President and CEO sold 8,568 shares at $5.24 ($44,896)
  19. 4 Grant or award Chief Financial Officer acquired 38,800 shares (grant or award)
  20. 144 Insider Sale of Securities

Page 10 of 53 · 1,058 filings